Log in to save to my catalogue

Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the...

Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0b57202eae1c49b0a131f97167cc4177

Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the United States

About this item

Full title

Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the United States

Publisher

United States: John Wiley & Sons, Inc

Journal title

Cancer medicine (Malden, MA), 2022-12, Vol.11 (23), p.4440-4448

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
It is not clear if all Americans have benefitted equally from the availability of chimeric antigen receptor T‐cell (CART) therapy. We aimed to evaluate if demographic differences existed among adult patients who received CART therapy and to assess predictors of CART treatment outcomes.
Methods
Records of patients ≥18 years who r...

Alternative Titles

Full title

Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the United States

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0b57202eae1c49b0a131f97167cc4177

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0b57202eae1c49b0a131f97167cc4177

Other Identifiers

ISSN

2045-7634

E-ISSN

2045-7634

DOI

10.1002/cam4.4797

How to access this item